By Abigail Townsend
Date: Wednesday 20 Oct 2021
(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.
By Abigail Townsend
Date: Tuesday 08 Jun 2021
(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.
By Alexander Bueso
Date: Friday 27 Nov 2020
(Sharecast News) - Biogen has inked a deal with Sage Therapeutics to jointly develop and sell potentially "breakthrough" treatments for major depressive and movement disorders in the US.
Currency | US Dollars |
Share Price | $ 158.79 |
Change Today | $ 0.89 |
% Change | 0.56 % |
52 Week High | $267.71 |
52 Week Low | $155.43 |
Volume | 900,976 |
Shares Issued | 144.90m |
Market Cap | $23,009m |
RiskGrade | 259 |
Strong Buy | 9 |
Buy | 13 |
Neutral | 14 |
Sell | 0 |
Strong Sell | 0 |
Total | 36 |
Time | Volume / Share Price |
14:43 | 100 @ $158.79 |
14:43 | 100 @ $158.80 |
14:43 | 100 @ $158.80 |
14:43 | 100 @ $158.80 |
14:43 | 100 @ $158.80 |
You are here: research